Related Experiment Video
Updated: Aug 23, 2026

Measuring Uptake of the Glucose Analog, 6-(N-(7-Nitrobenz-2-Oxa-1,3-Diazol-4-yl)Amino)-6-Deoxyglucose, in Intact Murine Neural Retina
Published on: March 14, 2025
[Neonatal screening of glucose-6-phosphate dehydrogenase deficiency in umbilical cord blood]
F Kaddari1, M Sawadogo, J Sancho
1Laboratoire d'immunologie-biochimie, Centre hospitalier Delafontaine, 93205 Saint-Denis.
Insights
Glucose-6-phosphate dehydrogenase (G6PD) deficiency screening is crucial for newborns, especially in at-risk populations. A new automated blood test using umbilical cord blood was developed to detect this common enzyme deficiency.
Area of Science:
- Biochemistry
- Genetics
- Neonatology
Background:
- Glucose-6-phosphate dehydrogenase (G6PD) deficiency is the most common enzyme disorder globally.
- It is a sex-linked genetic condition primarily affecting African, Mediterranean, and Far-Eastern populations.
- Clinical manifestations include hemolytic anemia and neonatal jaundice.
Purpose of the Study:
- To develop and validate an automated blood screening test for G6PD deficiency in neonates.
- To establish normal reference values for G6PD and ASAT in umbilical cord blood.
- To determine the genetic frequency of G6PD deficiency in newborns.
Main Methods:
- Development of an automated assay for G6PD enzyme activity.
- Utilization of red blood cell aspartate-amino-transferase (ASAT) as a reference enzyme to assess red blood cell age.
- Analysis of 235 umbilical cord blood samples to calculate normal values and frequency.
Main Results:
- Established normal ranges for G6PD, ASAT, and the G6PD/ASAT ratio in cord blood.
- Determined the genetic frequency of G6PD deficiency to be 6% in males and 1% in females in 2002.
- Successfully automated the G6PD assay for efficient neonatal screening.
Conclusions:
- The developed automated test is suitable for neonatal screening of G6PD deficiency.
- Neonatal screening for G6PD deficiency is essential, particularly in populations with a high prevalence.
- The study provides baseline data on G6PD deficiency frequency in newborns.
Abstract:
Glucose-6-phosphate dehydrogenase (G6PD) deficiency is the most frequent enzyme deficiency. It is a sex-linked genetic disease concerning mostly african, mediterranean and far-eastern populations. The main clinical expression is a hemolytic anemia which can be acute or chronic. During the neonatal period the disease may manifest as neonatal jaundice. We have been asked by the neonate department to set up a blood screening test for this deficiency. We have therefore developed a test using umbilical cord blood. The assay of G6PD has been automatised and red blood cell aspartate-amino-transferase (ASAT) chosen as a reference enzyme to evaluate the age of red blood cells. Normal values of G6PD, ASAT and G6PD/ASAT ratio have been calculated from 235 cord samples. Genetic frequency of this deficiency in 2002 was 6% in male and 1% in female newborns.
Related Concept Videos
Glucose Transporters
Facilitated diffusion-glucose transporters (GLUTs) are encoded by the solute-linked carrier (SLC) family 2, subfamily A gene family, or SLC2A. The 14 GLUT protein members are distributed into three classes:
Inborn Errors of Metabolism
Pathophysiology of Diabetes
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility, suggesting a...

